BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 6,000 shares, a growth of 500.0% from the September 15th total of 1,000 shares. Based on an average daily volume of 460 shares, the short-interest ratio is currently 13.0 days. Currently, 0.0% of the shares of the stock are short sold.
BioNxt Solutions Stock Up 23.1%
BNXTF stock opened at $0.26 on Friday. BioNxt Solutions has a 52 week low of $0.14 and a 52 week high of $0.79. The company has a fifty day simple moving average of $0.25 and a two-hundred day simple moving average of $0.28. The firm has a market capitalization of $35.61 million, a P/E ratio of -5.23 and a beta of 0.70.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last released its quarterly earnings results on Friday, August 28th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc is a life sciences company focused on developing drug-delivery and diagnostic technologies. The company’s platform areas include orally dissolvable thin-film formulations, transdermal delivery systems and diagnostic products designed to support more convenient and efficient administration of pharmaceutical treatments.
BioNxt’s development programs have included oral thin-film versions of established pharmaceutical compounds, as well as technologies intended for applications in neurological, infectious-disease and other therapeutic areas.
See Also
- Five stocks we like better than BioNxt Solutions
- The Grocery Shelf Battle Is Changing—Who Comes Out Ahead?
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
